Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level

Clinical trial NCT01396070 · COMPLETED

Trial details

NCT number: NCT01396070
Sponsor: Youn Kim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma (NHL)Cutaneous Lymphoma Cutaneous T-cell Lymphoma (CTCL)Mycosis Fungoides Sezary Syndrome

Start date: 2011-05-01
Primary completion: 2015-04-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.